Ongoing Clinical Trials

Intraoperative integration of artificial intelligence during cystoscopic surgery (bladder).

Principal Investigator: Joseph Liao, MD

The Canary Multi-Institutional Tissue Microarray Resource of Prostate Cancer.

Principal Investigator: James Brooks, MD

Customized Ablation of the Prostate with the TULSA Procedure Against radIcal prostatectomy treatmeNt: a randomized controlled trial for localized prostate cancer (CAPTAIN).

Principal Investigator: Geoffrey Sonn, MD

Urologic Consultation for Difficult/ traumatic urethral catheterization database.

Principal Investigator: Jay Shah, MD

Compassionate use for Anktiva.

Principal Investigator: Kris Prado, MD

Performance of urine tumor DNA detection in muscle-invasive bladder cancer patients undergoing recommended cystectomy.

Principal Investigator: Eugene Shkolyar, MD

Performance of urine tumor DNA detection in high-grade non-muscle-invasive bladder cancer patients undergoing recommended repeat transurethral resection.

Principal Investigator: Eugene Shkolyar, MD

The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy.

Principal Investigator: Jay Shah, MD

A prospective, multicentred, single arm, open-label, feasibility study to evaluate the safety and initial effectiveness of “HyperQureTM RDN System”, laparoscopic renal denervation therapy, in patients with hypertension in the absence of antihypertensive medications (Off-Med).

Principal Investigator: Benjamin Chung, MD, MS

Analysis of urine tumor nucleic acids for detection and personalized surveillance of bladder cancer.

Principal Investigator: Joseph Liao, MD

Edrn Prostate MRI Biomarker Study and Reference Set.

Principal Investigator: Geoffrey Sonn, MD

international REgistry of COnservative or Radical treatment of localized kiDney tumors (i-RECORD).

Principal Investigator: Benjamin Chung, MD, MS

Kidney surgery database.

Principal Investigator: Benjamin Chung, MD, MS

Predicting Location and Extent of Prostate Cancer using Micro-Ultrasound Imaging.

Principal Investigator: Geoffrey Sonn, MD

Active Surveillance and Patient Reported Outcomes in a Diverse Population of Prostate Cancer Patients.

Principal Investigator: Benjamin Chung, MD, MS

Prostate Active Surveillance Study (PASS).

Principal Investigator: James Brooks, MD

Phase 3, Randomized Study of CG0070 versus Observation for the Treatment of Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR-NMIBC) Following Transurethral Resection of Bladder Tumor (TURBT).

Principal Investigator: Eila Skinner, MD

A Randomised Controlled Trial comparing MRI-Ultrasound fusion and Cognitive-guided biopsy for the detection of clinically significant Prostate cancer: the PROFUSION trial.

Principal Investigator: Geoffrey Sonn, MD

Perioperative and survival outcomes for prostate cancer across minimally invasive (MIS) and/or open surgical interventions with or without neoadjuvant systemic and/or adjuvant systemic therapies.

Principal Investigator: Benjamin Chung, MD, MS

Quality of Life Survey - Urine Sample Study Participation Assessment.

Principal Investigator: Eugene Shkolyar, MD

Evaluation of patient frailty using CT imaging to predict outcomes after radical cystectomy.

Principal Investigator: Jay Shah, MD

Retrospective Study of Molecular and Imaging Biomarkers to Predict Response to Therapy for Cancer Patients.

Principal Investigator: Guolan Lu, PhD

S1802, Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer.

Principal Investigator: Geoffrey Sonn, MD

SGN22E-004 / EV-104: A study of intravesical enfortumab vedotin for treatment of patients with non-muscle invasive bladder cancer (NMIBC).

Principal Investigator: Eila Skinner, MD

Surgery in Early Metastatic Seminoma (SEMS): Phase II trial of retroperitoneal lymph node dissection as first-line treatment for testicular seminoma with isolated retroperitoneal disease (1-3cm).

Principal Investigator: Eila Skinner, MD

Stockholm3 Validation Study in a Multi-Ethnic Cohort (SEPTA).

Principal Investigator: Geoffrey Sonn, MD

A Serum Marker for Aggressive Prostate Cancer.

Principal Investigator: James Brooks, MD

UrineTumor DNA Guided TAR-200 Intensification of Non-Muscle Invasive Bladder Cancer Therapy.

Principal Investigator: Joseph Liao, MD

Biomarkers and Clinical Parameters Associated with Gleason Score Upgrading.

Principal Investigator: James Brooks, MD

Preserving erectile function by quantifying the nerve-sparing step of the robotic prostatectomy.

Principal Investigator: Geoffrey Sonn, MD

Perioperative and survival outcomes for pure and variant histology urothelial carcinomas of the upper tract, urinary bladder and urethra across endoscopic, minimally invasive (MIS) and/or surgical interventions with or without neoadjuvant systemic and/or adjuvant systemic or local therapies.

Principal Investigator: Benjamin Chung, MD, MS

Personalized assessment of bladder cancer treatment response using urinary molecular biomarkers.

Principal Investigator: Joseph Liao, MD

Leveraging Artificial Network.

Principal Investigator: Joseph Liao, MD

Phase 3, Randomized Study of CG0070 versus Observation for the Treatment of Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR-NMIBC) Following Transurethral Resection of Bladder Tumor (TURBT).

Principal Investigator: Eugene Shkolyar, MD

Artificial intelligence analysis of histopathology slides to predict response to bladder cancer therapy.

Principal Investigator: Jay Shah, MD

Advancing AI-Enabled Ambulatory Urodynamics of Improved Diagnosis of Bladder Outlet Obstruction and Refractory OAB.

Principal Investigator: None

A Real World Study of eCoin® for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE).

Principal Investigator: Craig Comiter, MD

OAB Digital Health.

Principal Investigator: Ekene Enemchukwu, MD, MPH, FACS, URPS

Outcomes in Refractory Overactive Bladder Outcomes: An OAB Registry Study.

Principal Investigator: Ekene Enemchukwu, MD, MPH, FACS, URPS

Improving Overactive Bladder Treatment Access and Adherence through Personalized Behavioral Modifications and Mobile Technology-Based Interventions.

Principal Investigator: Ekene Enemchukwu, MD, MPH, FACS, URPS

Observational study of sacral neuromodulation for lower urinary tract symptoms associated with multiple sclerosis.

Principal Investigator: Ekene Enemchukwu, MD, MPH, FACS, URPS

SOPHIA 2: Pivotal Study to assess the Safety and Effectiveness of the UrOActive artificial urinary sPHincter In the treAtment of Stress Urinary Incon.

Principal Investigator: Craig Comiter, MD

Utilization of 3rd-line therapies in OAB Medicare Beneficiaries.

Principal Investigator: Ekene Enemchukwu, MD, MPH, FACS, URPS

Utilization of Vaginal Estrogen in Medicare Beneficiaries.

Principal Investigator: Ekene Enemchukwu, MD, MPH, FACS, URPS

A prospective, randomized, controlled, blinded study to assess the Safety and Efficacy of the Butterfly Medical Prostatic Retraction Device in Benign Prostatic Hyperplasia (BPH) Patients [CA].

Principal Investigator: Craig Comiter, MD

MagSTONE: a magnetic system for kidney stone fragment elimination.

Principal Investigator: Joseph Liao, MD

Quantifying Surgical Feedback with Artificial Intelligence.

Principal Investigator: Simon Conti, MD

Treatment of Ureteral Stent Pain with a Transcutaneous Electrical Nerve Stimulator (TENS for US).

Principal Investigator: Simon Conti, MD

CystoNet-database (Kidney stone, urinary tract procedure, etc.).

Principal Investigator: Timothy Chang, MD

Economic Burden of Stent Related Complications Post Urological Procedures.

Principal Investigator: Kathleen Kan, MD

Evaluating the use of scrotal ultrasounds in cases of undescended testes.

Principal Investigator: Kathleen Kan, MD

Hydronephrosis Registry.

Principal Investigator: Kathleen Kan, MD

Identification of Urinary and Blood Markers of Kidney Damage.

Principal Investigator: Kathleen Kan, MD

Identifying Incidents and Risk Factors for Urethral Catheterization Trauma.

Principal Investigator: Kathleen Kan, MD

Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants.

Principal Investigator: Kathleen Kan, MD

Developing a novel workshop to achieve consensus on elementary school bathroom policies using a community-engaged approach.

Principal Investigator: Kathleen Kan, MD

The Utility of Contrast Enhanced Ultrasound (CEUS) with Microbubbles for Kidney Imaging to Determine Differential Renal Function.

Principal Investigator: Daniel Han, MD

National Trends in Pediatric Urology Procedures and Factors Associated with Patient Outcomes.

Principal Investigator: Kathleen Kan, MD

Retrospective analysis of US acoustic properties in patients with pyelonephritis.

Principal Investigator: Daniel Han, MD

Retrospective evaluation of the use of scrotal ultrasounds in cases of undescended testes.

Principal Investigator: Kathleen Kan, MD

The use of three-dimensional ultrasound to assess parenchymal volume of hydronephrotic kidneys and utilize ratio of collecting system to parenchymal volume ratio as a predictive factor for clinically significant hydronephrosis requiring surgical intervention.

Principal Investigator: Daniel Han, MD

The Utility of Ultrasound Imaging for the Detection of Acoustic Property Changes in Kidneys with Pyelonephritis.

Principal Investigator: Daniel Han, MD

Understanding and Enhancing Schoolchildren's Bathroom Habits: Uncovering Barriers and Promoting Healthy Bladder Habits.

Principal Investigator: Kathleen Kan, MD

Understanding the knowledge, behavior change, engagement and retention of the key stakeholders of Bladder Basics.

Principal Investigator: Kathleen Kan, MD

Tumor Volume Change During Pre-Nephrectomy Chemotherapy For Patients with Unilateral Wilms Tumor.

Principal Investigator: Daniel Han, MD

Use of minimally invasive techniques in pediatric urology.

Principal Investigator: Daniel Han, MD

Voiding dysfunction in pre-K and elementary school children's survey of beliefs among stakeholders regarding promotion of favorable lower urinary tract health.

Principal Investigator: Kathleen Kan, MD

Aldehyde Dehydrogenase and Potential Implications for Fertility.

Principal Investigator: Michael Eisenberg, MD

Aldehyde dehydrogenase and potential implications for fertility bench top experiments.

Principal Investigator: Michael Eisenberg, MD

An internet-based study of time-to-pregnancy in North America.

Principal Investigator: Michael Eisenberg, MD

A Cross-Sport Analysis of Urologic Injuries in Young Athletes: Patterns and Prevalence.

Principal Investigator: Michael Eisenberg, MD

The Association between Cryotherapy and Semen Quality.

Principal Investigator: Michael Eisenberg, MD

Double-S: A Wearable for Erectile Dysfunction.

Principal Investigator: Michael Eisenberg, MD

Lab Misc. (Writing papers, DUA's, research projects for other lab members, lab website, etc).

Principal Investigator: Michael Eisenberg, MD

With Muscle-Invasive Urothelial Carcinoma (MIBC) of the Bladder who are not Receiving.

Principal Investigator: Michael Eisenberg, MD

Male Contraceptive Protocol.

Principal Investigator: Michael Eisenberg, MD

Effects of commonly prescribed medications on male fertility.

Principal Investigator: Michael Eisenberg, MD

Microplastics in the Genitourinary System.

Principal Investigator: Michael Eisenberg, MD

Male Infertility Database MOBYUS project.

Principal Investigator: Tony Chen, MD

Nerve stimulation for post-prostatectomy men.

Principal Investigator: Michael Eisenberg, MD

Non-invasive external device for erectile dysfunction (3D-Erect): a pilot study.

Principal Investigator: Michael Eisenberg, MD

Prostate Stimulation for Sexual Dysfunction.

Principal Investigator: Michael Eisenberg, MD

Platelet Rich Plasma Testis.

Principal Investigator: Michael Eisenberg, MD

Retrospective investigation of epidemiological factors associated with male infertility.

Principal Investigator: Michael Eisenberg, MD

Sperm Analysis as a Predictor of Future Health Outcomes.

Principal Investigator: Michael Eisenberg, MD

Testicular tissue Cryopreservation for Prepubescent and Adolescent Boys for Future Fertility.

Principal Investigator: Michael Eisenberg, MD

Understanding Spermatogenesis and Seminiferous Tubules Biology.

Principal Investigator: Michael Eisenberg, MD

Interventional
Non-Interventional

Urologic Oncology

A prospective, multicenter, single arm, open-label, early feasibility study to evaluate initial safety and device design concept of “HyperQure^TM RDN System”, laparoscopic renal denervation therapy, in patients with resistant hypertension on three (3) or more antihypertensive medications

Principal Investigator: Benjamin I. Chung, MD
Contact: Ned Realiza nrealiza@stanford.edu
ClinicalTrials.gov#: NCT06526858

Customized Ablation of the Prostate with the TULSA Procedure Against radIcal prostatectomy treatmeNt: a randomized controlled trial for localized prostate cancer (CAPTAIN)

Principal Investigator: Geoffrey Sonn, MD
Contact: Julia Gallagher-Teske jgteske@stanford.edu
ClinicalTrials.gov#: NCT05027477

Phase 3, Randomized Study of CG0070 versus Observation for the Treatment of Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR-NMIBC) Following Transurethral Resection of Bladder Tumor (TURBT)

Principal Investigator: Eila C. Skinner, MD, Eugene Shkolyar, MD
Contact: Kristine Talavera kriscima@stanford.edu
ClinicalTrials.gov#: NCT06111235

A Phase III Study of Cabazitaxel with or without Carboplatin in Patients with Metastatic Castrate Resistant Prostate Cancer (MCRPC), Stratified by Aggressive Variant Signature

Principal Investigator: Sandy Srinivas, MD
Contact: Sneha Mohile smohile@stanford.edu
ClinicalTrials.gov#: NCT06470243

MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of Adjuvant Therapy in Urothelial Cancer

Principal Investigator: Ali Raza Khaki, MD
Contact: Sneha Mohile smohile@stanford.edu
ClinicalTrials.gov#: NCT05987241

EA8192 A Phase II/III trial of Durvalumab and Chemotherapy for Patients with High Grade Upper Tract Urothelial Cancer Prior to Nephroureterectomy

Principal Investigator: Ali Raza Khaki, MD
Contact: Sneha Mohile smohile@stanford.edu
ClinicalTrials.gov#: NCT04628767

AGCT1532 Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours (P3BEP)

Principal Investigator: Sandy Srinivas, MD
Contact: Sneha Mohile smohile@stanford.edu
ClinicalTrials.gov#: NCT02582697

CCTG.PR26 TRIPLE SWITCH Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response (TRIPLE-SWITCH), NCT #06592924

Principal Investigator: Ali Raza Khaki, MD
Contact: Sneha Mohile smohile@stanford.edu
ClinicalTrials.gov#: NCT06592924

Urology

A Real World Study of eCoin® for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

Principal Investigator: Craig Comiter, MD
Contact: Julia Gallagher-Teske jgteske@stanford.edu
ClinicalTrials.gov#: NCT05685433

Double-s: A Wearable for Erectile Dysfunction

Principal Investigator: Michael Eisenberg, MD
Contact: Satvir Basran sbasran@stanford.edu
ClinicalTrials.gov#: NCT05451563

Prostate stimulation for sexual dysfunction

Principal Investigator: Michael Eisenberg, MD
Contact: Satvir Basran sbasran@stanford.edu
ClinicalTrials.gov#: NCT05468931

Nerve Stimulation for Post Prostatectomy Men

Principal Investigator: Michael Eisenberg, MD
Contact: Satvir Basran sbasran@stanford.edu
ClinicalTrials.gov#: N/A

Meet Our Team

Satvir Basran

Clinical Research Coordinator
Email: sbasran@stanford.edu

Rachelle Balili Kanegawa

Clinical Research Coordinator
Email: rbalili@stanford.edu

Vinh la

Clinical Research Coordinator
Email: vinhla96@stanford.edu

Sneha Mohile

Clinical Research Coordinator
Email: smohile@stanford.edu

Ned Realiza

Clinical Research Manager
Email: nrealiza@stanford.edu

Gabriela (Gaby) Rodriguez

Clinical Research Coordinator
Email: grod094@stanford.edu

Meredith West

Clinical Research Coordinator/ Data Analyst
Email: mwest2@stanford.edu

From left to right: Rachelle Balili, Satvir Basran, Sophia Prendiville, Gaby Rodriguez, Julia Gallagher-Teske, Kristine Talavera, Ned Realiza, Sneha Mohile.